Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors

BACKGROUND: The modified Glasgow prognostic score (mGPS), a clinical tool that incorporates albumin and C‐reactive protein, has proven useful in the prognostication of multiple cancers. Several immune checkpoint inhibitors (ICIs) have been approved for the treatment of metastatic urothelial cell car...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncologist
Auteurs principaux: Brown, Jacqueline T., Liu, Yuan, Shabto, Julie M., Martini, Dylan J., Ravindranathan, Deepak, Hitron, Emilie Elise, Russler, Greta Anne, Caulfield, Sarah, Yantorni, Lauren Beth, Joshi, Shreyas S., Kissick, Haydn, Ogan, Kenneth, Harris, Wayne B., Carthon, Bradley C., Kucuk, Omer, Master, Viraj A., Bilen, Mehmet Asim
Format: Artigo
Langue:Inglês
Publié: John Wiley & Sons, Inc. 2021
Sujets:
Genitourinary Cancer
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8100543/
https://ncbi.nlm.nih.gov/pubmed/33634507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13727
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires